Moderna (MRNA)

Deferred Revenue

$295.00M

Quarterly · Period ending: · USD

MRNA logo

MRNA Deferred Revenue

Latest reported$295.00M
MRNA Quarterly Deferred Revenue ($0.00 → $295.00M)
High-resolution chart · PNG

MRNA deferred revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Moderna Deferred Revenue — Quarterly (USD)
Period endingDeferred Revenue (USD)
295,000,000
102,000,000
99,000,000
163,000,000
218,000,000
125,000,000
153,000,000
379,000,000
702,000,000
559,000,000
568,000,000
1,372,000,000
1,040,000,000
1,219,000,000
2,038,000,000
4,002,000,000
4,093,000,000
5,599,000,000
6,253,000,000
7,977,000,000
7,302,000,000
7,531,000,000
3,867,000,000
1,234,506,000
45,244,000
58,842,000
63,310,000
70,191,000
83,401,000
73,958,000
109,056,000
115,409,000
0
0
96,739,000
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.